RYZUP Support Services logo

RYZUP offers several access
and affordability programs

Enrollment in RYZUP is required to ensure your patients receive LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) as prescribed.

RYZUP Support Services logo

RYZUP offers several access and affordability programs

Enrollment in RYZUP is required to ensure your patients receive LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) as prescribed.

As little as $0 co-pay for eligible patients with commercial insurance*

*Except where prohibited by state law. Some people will not qualify for certain affordability programs. Avadel reserves the right to rescind, revoke, and amend terms and conditions of affordability programs without notice. Please see full terms and conditions of the co-pay program below.

Patient icon

Temporary Access Program (TAP)

Temporary treatment is available for eligible patients who have commercial insurance and are experiencing coverage delays for LUMRYZ.
Phone icon

Patient Assistance Program (PAP)

Treatment is available free of charge to eligible patients who complete the RYZUP PAP Application and who are uninsured or underinsured for LUMRYZ and meet certain financial and other criteria.

LUMRYZ™ Co-Pay Program Terms and Conditions

In order to participate in the LUMRYZ Copay Program and receive the benefit, a patient must meet the eligibility criteria and comply with the terms and conditions described below:

  • This Program offer is only valid for patients who have a valid LUMRYZ prescription and who have commercial insurance coverage for LUMRYZ. Patients with commercial insurance that does not provide formulary coverage for LUMRYZ are NOT eligible for the Copay Program. No substitutions are permitted.
  • This Program offer is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, Tricare or other federal or state healthcare programs (including any state prescription drug assistance programs).
  • This Program offer is not valid for uninsured or cash paying patients.
  • Eligible patients may pay as little as $0 on each fill. Maximum benefit limits per prescription and annual benefit limits per individual apply and out of pocket expenses may vary. If the prior authorization is approved by the commercial insurer, then the patient remains eligible for the Copay Program. If the prior authorization is denied by the commercial insurer, then the patient is no longer eligible for the Copay Program and may not receive any additional Copay Program benefits. If you have any questions regarding your eligibility or benefits, please call 1-844-485-7636.
  • This Program offer is not valid as a primary claim for patients.
  • The Program offer is not valid for prescriptions that are eligible to be reimbursed by private insurance plans, other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription.
  • This Copay Program is not health insurance. Patients may not seek reimbursement for the value received from the Copay Program from any third-party payers, including the patient’s commercial insurer, a flexible spending account or health-care savings account. This Program offer is not valid if your insurance plan or pharmacy benefit manager prohibits use of manufacturer copay cards. By participating in this Copay Program, you agree you are responsible for ensuring you comply with any required disclosure of your insurance plan or pharmacy benefit manager.
  • The Program offer cannot be combined with any other financial assistance program, rebate/coupon, free trial, discount, prescription savings card or other offer.
  • This Program offer is only valid for residents of the United States. Patients residing in or receiving treatment in certain states may not be eligible. This offer is not valid in Massachusetts or where otherwise prohibited by law.
  • The Program offer is only available at participating pharmacies.
  • Avadel reserves the right to make eligibility determinations, to set program benefit maximums, to monitor participation, and to change, rescind, revoke, or discontinue the Copay Program at any time without notice.
  • The selling, purchasing, trading, or counterfeiting of any benefit provided under the Copay Program is prohibited. This Program offer is non-transferable.
  • Data related to an eligible patient's receipt of Copay Program benefits may be collected, analyzed and shared with Avadel CNS Pharmaceuticals, LLC, and companies working on Avadel's behalf, for market research and other purposes (including helping to verify or coordinate insurance coverage) related to assessing Avadel's Copay Program. Data shared by eligible patients with Avadel will be aggregated and de-identified; it will not identify any individual patient.
  • If you have any questions regarding this Copay Program, your eligibility or benefits or if you wish to discontinue your participation, please call 1-844-485- 7636.
  • These Terms and Conditions are valid for LUMRYZ dispensed between 1/1/2024 and 12/31/2024. Expiration Date: 12/31/2024.